Logo image of XIN

XINYUAN REAL ESTATE CO L-ADR (XIN) Stock Fundamental Analysis

NYSE:XIN - New York Stock Exchange, Inc. - US98417P2048 - ADR - Currency: USD

2.13  +0.03 (+1.43%)

Fundamental Rating

1

Taking everything into account, XIN scores 1 out of 10 in our fundamental rating. XIN was compared to 64 industry peers in the Real Estate Management & Development industry. XIN has a bad profitability rating. Also its financial health evaluation is rather negative. XIN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year XIN has reported negative net income.
In the past year XIN had a positive cash flow from operations.
XIN had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: XIN reported negative operating cash flow in multiple years.
XIN Yearly Net Income VS EBIT VS OCF VS FCFXIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

XIN's Return On Assets of -1.01% is in line compared to the rest of the industry. XIN outperforms 57.81% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.42%, XIN is in the better half of the industry, outperforming 67.19% of the companies in the same industry.
Industry RankSector Rank
ROA -1.01%
ROE N/A
ROIC 2.42%
ROA(3y)-1.59%
ROA(5y)-2.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XIN Yearly ROA, ROE, ROICXIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

XIN has a Operating Margin of 7.63%. This is in the better half of the industry: XIN outperforms 76.56% of its industry peers.
In the last couple of years the Operating Margin of XIN has declined.
With a Gross Margin value of 16.12%, XIN is not doing good in the industry: 60.94% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of XIN has declined.
Industry RankSector Rank
OM 7.63%
PM (TTM) N/A
GM 16.12%
OM growth 3YN/A
OM growth 5Y-9.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y53.91%
GM growth 5Y-6.51%
XIN Yearly Profit, Operating, Gross MarginsXIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so XIN is still creating some value.
The number of shares outstanding for XIN has been reduced compared to 1 year ago.
The number of shares outstanding for XIN has been increased compared to 5 years ago.
Compared to 1 year ago, XIN has an improved debt to assets ratio.
XIN Yearly Shares OutstandingXIN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
XIN Yearly Total Debt VS Total AssetsXIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.10, we must say that XIN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.10, XIN is doing worse than 64.06% of the companies in the same industry.
XIN has a debt to FCF ratio of 103.68. This is a negative value and a sign of low solvency as XIN would need 103.68 years to pay back of all of its debts.
The Debt to FCF ratio of XIN (103.68) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 103.68
Altman-Z 0.1
ROIC/WACC1.49
WACC1.62%
XIN Yearly LT Debt VS Equity VS FCFXIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.12 indicates that XIN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.12, XIN is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
XIN has a Quick Ratio of 1.12. This is a bad value and indicates that XIN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.27, XIN is doing worse than 89.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.27
XIN Yearly Current Assets VS Current LiabilitesXIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

0

3. Growth

3.1 Past

XIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -215.38%.
XIN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.04%.
The Revenue for XIN have been decreasing by -26.99% on average. This is quite bad
EPS 1Y (TTM)-215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.33%
Revenue 1Y (TTM)-36.04%
Revenue growth 3Y-30.53%
Revenue growth 5Y-26.99%
Sales Q2Q%-13.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XIN Yearly Revenue VS EstimatesXIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

XIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XIN Price Earnings VS Forward Price EarningsXIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, XIN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.69
EV/EBITDA N/A
XIN Per share dataXIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XINYUAN REAL ESTATE CO L-ADR

NYSE:XIN (6/18/2025, 8:04:00 PM)

2.13

+0.03 (+1.43%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Inst Owners0.52%
Inst Owner Change14.13%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.96M
Analysts80
Price TargetN/A
Short Float %0.21%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)-57.09%
DP-6.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.69
P/OCF 0.66
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.98
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.1
FCFY145.6%
OCF(TTM)3.21
OCFY150.54%
SpS91.74
BVpS-18.7
TBVpS-18.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.01%
ROE N/A
ROCE 3.22%
ROIC 2.42%
ROICexc 2.42%
ROICexgc 2.42%
OM 7.63%
PM (TTM) N/A
GM 16.12%
FCFM 3.38%
ROA(3y)-1.59%
ROA(5y)-2.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-26.22%
ROICexc growth 3YN/A
ROICexc growth 5Y-26.22%
OM growth 3YN/A
OM growth 5Y-9.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y53.91%
GM growth 5Y-6.51%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 103.68
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.11%
Interest Coverage 1.03
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.27
Altman-Z 0.1
F-Score3
WACC1.62%
ROIC/WACC1.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.04%
Revenue growth 3Y-30.53%
Revenue growth 5Y-26.99%
Sales Q2Q%-13.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.4%
EBIT growth 3YN/A
EBIT growth 5Y-33.94%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.42%
FCF growth 3Y-49.29%
FCF growth 5Y-42.07%
OCF growth 1Y106.64%
OCF growth 3Y-48.99%
OCF growth 5Y-41.92%